Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
British Journal of Clinical Pharmacology
|
August 29, 2006
Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products
James W Dear, Pajaree Lilitkarntakul, David J Webb
Hypertension (Dallas, Tex. : 1979)
|
April 21, 2010
Greater functional ETB receptor antagonism with bosentan than sitaxsentan in healthy men
Iain M MacIntyre, Neeraj Dhaun, Pajaree Lilitkarntakul, et al.
Diabetes Care
|
June 1, 2012
Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidity
Pajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 10, 2010
Renal dysfunction does not affect the peripheral-to-central arterial pressure transfer function
Rupert A Payne, Pajaree Lilitkarntakul, Neeraj Dhaun, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 5, 2009
Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney disease
Neeraj Dhaun, Iain M Macintyre, Vanessa Melville, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 10, 2009
Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease
Neeraj Dhaun, Iain M Macintyre, Vanessa Melville, et al.
American Journal of Physiology. Renal Physiology
|
March 13, 2009
Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis
Neeraj Dhaun, Pajaree Lilitkarntakul, Iain M Macintyre, et al.
Atherosclerosis
|
March 8, 2011
Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity
Pajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
British Journal of Clinical Pharmacology
|
August 29, 2006
Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products
James W Dear, Pajaree Lilitkarntakul, David J Webb
Hypertension (Dallas, Tex. : 1979)
|
April 21, 2010
Greater functional ETB receptor antagonism with bosentan than sitaxsentan in healthy men
Iain M MacIntyre, Neeraj Dhaun, Pajaree Lilitkarntakul, et al.
Diabetes Care
|
June 1, 2012
Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidity
Pajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 10, 2010
Renal dysfunction does not affect the peripheral-to-central arterial pressure transfer function
Rupert A Payne, Pajaree Lilitkarntakul, Neeraj Dhaun, et al.
Hypertension (Dallas, Tex. : 1979)
|
August 5, 2009
Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney disease
Neeraj Dhaun, Iain M Macintyre, Vanessa Melville, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 10, 2009
Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease
Neeraj Dhaun, Iain M Macintyre, Vanessa Melville, et al.
American Journal of Physiology. Renal Physiology
|
March 13, 2009
Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis
Neeraj Dhaun, Pajaree Lilitkarntakul, Iain M Macintyre, et al.
Atherosclerosis
|
March 8, 2011
Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity
Pajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, et al.
Page
of 1